Abstract |
Specialized pro-resolving mediators (SPM), primarily produced in innate immune cells, exert crucial bioactions for resolving inflammation. Among various lipoxygenases (LOX), 15-LOX-1 is key for SPM biosynthesis, but cellular activation principles of 15-LOX-1 are unexplored. It was shown that 3-O-acetyl-11-keto-β-boswellic acid (AKBA) shifts 5-LOX regiospecificity from 5- to 12-lipoxygenation products. Here, it is demonstrated that AKBA additionally activates cellular 15-LOX-1 via an allosteric site accomplishing robust SPM formation in innate immune cells, particularly in M2 macrophages. Compared to ionophore, AKBA-induced LOX activation is Ca2+ - and phosphorylation-independent, with modest induction of 5-LOX products. AKBA docks into a groove between the catalytic and regulatory domains of 15-LOX-1 interacting with R98; replacement of R98 by alanine abolishes AKBA-induced 15-LOX product formation in HEK293 cells. In zymosan-induced murine peritonitis, AKBA strikingly elevates SPM levels and promotes inflammation resolution. Together, targeted allosteric modulation of LOX activities governs SPM formation and offers new concepts for inflammation resolution pharmacotherapy.
|
Authors | Friedemann Börner, Simona Pace, Paul M Jordan, Jana Gerstmeier, Mario Gomez, Antonietta Rossi, Nathaniel C Gilbert, Marcia E Newcomer, Oliver Werz |
Journal | Advanced science (Weinheim, Baden-Wurttemberg, Germany)
(Adv Sci (Weinh))
Vol. 10
Issue 6
Pg. e2205604
(02 2023)
ISSN: 2198-3844 [Electronic] Germany |
PMID | 36567268
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2022 The Authors. Advanced Science published by Wiley-VCH GmbH. |
Chemical References |
- boswellic acid
- Arachidonate 15-Lipoxygenase
- Lipoxygenase
- acetyl-11-ketoboswellic acid
- Lipids
- Scavenger Receptors, Class E
|
Topics |
- Humans
- Mice
- Animals
- Arachidonate 15-Lipoxygenase
- Lipoxygenase
- Allosteric Regulation
- HEK293 Cells
- Inflammation
(drug therapy)
- Lipids
- Scavenger Receptors, Class E
|